Physician profile
Matthew Bolinger
NPI 1144405747
$1,863.35
in general payments reported to CMS, 2019-2025
16 companies · $344 in 2025
The $344 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $127 · 2020: $105 · 2021: $153 · 2022: $918 · 2023: $145 · 2024: $71.40 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $526 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $526.42 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $697.27 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $530.82 | 2019-2025 | Dupixent, Libtayo |
| Glaxosmithkline, LLC. | $217.00 | 2021-2025 | Nucala |
| Genzyme Corporation | $90.07 | 2023-2025 | |
| Medtronic, INC. | $47.62 | 2025 | Nuvent |
| Axogen | $36.98 | 2025 | Axoguard Ha+ Nerve Protector |
| Amgen INC. | $34.00 | 2025 | |
| Acclarent, INC | $30.65 | 2019-2021 | |
| Aerin Medical INC. | $26.55 | 2025 | |
| Integra Lifesciences Corporation | $24.82 | 2024 | Inspira Air, Acclarent Aera, Trudi Probe |
| Intersect Ent, INC. | $23.68 | 2020 | |
| Ambu INC. | $22.22 | 2022 | |
| Dexcom, INC. | $22.12 | 2025 | Dexcom G6 Transmitter |
| Depuy Synthes Sales INC. | $21.34 | 2019 | |
| Optinose US, INC. | $20.11 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $18.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Bolinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.